CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-10 | JEFFS ROGER Director | Option exercise · Stock Option (Right to Buy) | −34,866 | 0 | ||
| 2019-10-10 | TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +68,837 | 68,837 | ||
| 2019-10-10 | Pizzie Nick Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +25,813 | 25,813 | ||
| 2019-10-10 | Marek David C Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +25,813 | 25,813 | ||
| 2019-09-26 | Pizzie Nick Chief Financial Officer | Purchase | +2,180 | $24.80 | $54K | 40,440 |
| 2019-09-04 | Marek David C Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2019-07-03 | JEFFS ROGER Director | Option exercise | +3,672 | $3.67 | $13K | 3,672 |
| 2019-07-03 | JEFFS ROGER Director | Option exercise | +39,948 | $2.85 | $114K | 43,620 |
| 2019-07-03 | JEFFS ROGER Director | Option exercise | +13,000 | $3.45 | $45K | 56,620 |
| 2019-07-03 | JEFFS ROGER Director | Option exercise · Stock Option (Right to Buy) | −3,672 | 7,344 | ||
| 2019-07-03 | JEFFS ROGER Director | Option exercise · Stock Option (Right to Buy) | −39,948 | 0 | ||
| 2019-07-03 | JEFFS ROGER Director | Option exercise · Stock Option (Right to Buy) | −13,000 | 0 | ||
| 2019-06-26 | Coleman Mark Director | Purchase | +15,800 | $23.10 | $365K | 668,848 |
| 2019-06-25 | Coleman Mark Director | Purchase | +400 | $23.25 | $9K | 653,048 |
| 2019-06-11 | Pizzie Nick Chief Financial Officer | Purchase | +1,920 | $20.80 | $40K | 1,920 |
| 2019-06-07 | Saad Mark E Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2019-06-07 | POTTER MYRTLE S Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2019-06-07 | Coleman Mark Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2019-06-07 | JEFFS ROGER Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2019-05-23 | Saad Mark E Director | Purchase | +3,500 | $22.33 | $78K | 7,002 |
Page 18 of 22 · 422 trades